Prelude Therapeutics Incorporated (PRLD) Balance Sheet: Assets & Liabilities

Prelude Therapeutics Incorporated (PRLD) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Prelude Therapeutics Incorporated reported total assets of $141.31M and total liabilities of $72.68M. Shareholders' equity was $68.64M, down 47.8% from $131.46M a year earlier. Total debt stood at $17.79M against $103.21M in cash and short-term investments, a net cash position of $85.42M. That puts debt-to-equity at 0.26, compared with 0.14 a year earlier.

Prelude Therapeutics Incorporated Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Prelude Therapeutics Incorporated (PRLD) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	35.26	12.47	25.29	30.61	31.83	218.31	18.88	15.60
Short-Term Investments	67.96	121.14	207.64	171.12	259.41	0.00	0.00	0.00
Cash & Short-Term Investments	103.21	133.61	232.94	201.73	291.23	218.31	18.88	15.60
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.48	2.28	2.65	2.65	3.88	2.50	1.35	0.00
Total Current Assets	105.69	135.90	235.59	204.38	295.12	220.81	20.22	15.60
Non-Current Assets
Property, Plant & Equipment (Net)	32.28	35.47	37.74	6.70	5.64	2.48	1.65	0.81
Other Non-Current Assets	3.35	4.15	4.34	9.42	4.35	0.30	0.00	0.00
Total Non-Current Assets	35.62	39.62	42.08	16.12	9.98	2.78	1.65	0.81
Total Assets	141.32	175.52	277.67	220.50	305.10	223.59	21.87	16.41
Current Liabilities
Accounts Payable	3.98	7.73	4.58	6.78	7.84	3.92	1.97	1.36
Short-Term Debt	2.74	2.70	1.48	1.83	1.74	0.00	0.26	0.00
Accrued Liabilities	4.43	5.42	15.77	6.89	9.62	7.04	-	-
Deferred Revenue	33.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	12.53	0.77	0.95	0.52	9.62	7.46	2.60	1.09
Total Current Liabilities	52.99	25.64	21.83	21.70	19.20	11.38	4.84	2.45
Non-Current Liabilities
Long-Term Debt	15.05	15.33	15.41	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	2.84	3.09	3.34	3.36	0.00	0.03	66.45	36.65
Total Non-Current Liabilities	19.68	18.42	18.75	3.36	0.00	0.03	66.45	36.65
Total Liabilities	72.68	44.06	40.58	25.06	19.20	11.41	71.28	39.10
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-683.06	-583.56	-456.39	-334.56	-219.12	-107.43	-50.50	-22.93
Accumulated Other Comprehensive Income	0.01	0.04	0.22	-1.69	-0.71	-223.59	0.00	-0.19
Additional Paid-in Capital	751.68	714.98	693.25	531.68	505.72	319.61	1.09	-36.17
Shares Outstanding	62.95	55.15	54.91	47.90	47.60	-	-	-
Total Stockholders' Equity	68.64	131.46	237.09	195.44	285.90	212.18	-49.41	-22.69
Total Liabilities & Equity	141.32	175.52	277.67	220.50	305.10	223.59	21.87	16.41

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Prelude Therapeutics Incorporated Balance Sheet

How much debt does Prelude Therapeutics Incorporated have?

Prelude Therapeutics Incorporated had total debt of $17.79M as of Dec 31, 2025, against $103.21M in cash and short-term investments. Its debt-to-equity ratio was 0.26. Total debt was $18.02M a year earlier.

What are Prelude Therapeutics Incorporated's total assets?

Prelude Therapeutics Incorporated reported total assets of $141.31M as of Dec 31, 2025, down 19.5% from $175.51M a year earlier. Total liabilities were $72.68M.

What is Prelude Therapeutics Incorporated's shareholders' equity?

Prelude Therapeutics Incorporated's shareholders' equity was $68.64M as of Dec 31, 2025, or about $1.09 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition